Literature DB >> 3019110

In vitro and in vivo effects of piroxicam on rat polymorphonuclear responsiveness after induction of two acute non-specific inflammatory reactions.

D P Huy, M Roch-Arveiller, M Lenoir, O Muntaner, A Thuret, J P Giroud.   

Abstract

The effect of piroxicam on rat polymorphonuclear leucocytes (PMN) has been studied in vitro and in vivo after the induction of two acute, non specific inflammatory reactions (pleurisies induced by calcium pyrophosphate crystals (CaPP) or isologous serum). An inhibition of chemotaxis by piroxicam has been demonstrated by two techniques, the filter and agarose assays in vivo and in vitro. An inhibition of random cell migration has been observed only at the higher drug concentration using agarose assay with CaPP-elicited cells. Piroxicam also inhibited superoxide anion generation and O2 consumption of CaPP- and serum-elicited cells. These findings suggest that piroxicam may have a direct effect on PMN responses and that this activity could, at least in part, contribute to its anti-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019110     DOI: 10.1007/bf01964998

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  20 in total

1.  Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes.

Authors:  R D Nelson; P G Quie; R L Simmons
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  [Repeated sampling of rat polymorphonuclear leucocytes from the pleural cavity. Application for the study of leucocyte chemotaxis (author's transl)].

Authors:  J P Giroud; M Roch-Arveiller; O Muntaner
Journal:  Nouv Rev Fr Hematol       Date:  1978

4.  Chemotaxis of inflammatory cells.

Authors:  R Snyderman; T R Tempel; S E Mergenhagen
Journal:  J Dent Res       Date:  1971 Mar-Apr       Impact factor: 6.116

Review 5.  Mechanism of action of drugs for treating inflammation and arthritis.

Authors:  J G Lombardino
Journal:  Eur J Rheumatol Inflamm       Date:  1983

6.  Piroxicam, a novel anti-inflammatory agent.

Authors:  E H Wiseman; Y H Chang; J G Lombardino
Journal:  Arzneimittelforschung       Date:  1976

7.  Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo.

Authors:  H B Kaplan; H S Edelson; H M Korchak; W P Given; S Abramson; G Weissmann
Journal:  Biochem Pharmacol       Date:  1984-02-01       Impact factor: 5.858

8.  Effect of some anti-inflammatory drugs on FMLP-induced chemotaxis and random migration of rat polymorphonuclear leucocytes.

Authors:  D Pham Huy; M Roch-Arveiller; O Muntaner; J P Giroud
Journal:  Eur J Pharmacol       Date:  1985-05-08       Impact factor: 4.432

9.  Inhibition of in vitro neutrophil responses to chemotactic factors by piroxicam.

Authors:  K Tanaka; K Kanaoka; M Egawa; N Abe; I Watanabe; S Hirai
Journal:  Jpn J Pharmacol       Date:  1984-06

10.  Characterization of the rat neutrophil formyl peptide chemotaxis receptor.

Authors:  W A Marasco; J C Fantone; R J Freer; P A Ward
Journal:  Am J Pathol       Date:  1983-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.